President and CEO Roger Pomerantz sold $1.9M of Seres Therapeutics, Inc.

Sold$1,933,197

$28.70Price

67,367Shares

−75%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Mon, May 2. Filed Wed, May 4, 5:06 PM ET, after the close. Not investment advice.